22nd Century Group (NASDAQ:XXII) Receives Sell (E+) Rating from Weiss Ratings

22nd Century Group (NASDAQ:XXII)‘s stock had its “sell (e+)” rating restated by equities researchers at Weiss Ratings in a report issued on Saturday,Weiss Ratings reports.

Separately, StockNews.com cut 22nd Century Group from a “hold” rating to a “sell” rating in a report on Tuesday, December 31st.

22nd Century Group Price Performance

Shares of XXII opened at $1.71 on Friday. 22nd Century Group has a 12-month low of $1.68 and a 12-month high of $581.85. The business has a 50-day simple moving average of $3.40 and a two-hundred day simple moving average of $12.53. The company has a quick ratio of 0.93, a current ratio of 1.09 and a debt-to-equity ratio of 1.59. The stock has a market cap of $2.94 million, a PE ratio of 0.00 and a beta of 1.67.

Institutional Investors Weigh In On 22nd Century Group

A hedge fund recently bought a new stake in 22nd Century Group stock. Anson Funds Management LP purchased a new stake in 22nd Century Group, Inc. (NASDAQ:XXII) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned about 6.77% of 22nd Century Group at the end of the most recent quarter. 18.06% of the stock is currently owned by hedge funds and other institutional investors.

About 22nd Century Group

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.